TrialHaematologica2014

Risk factors for Epstein-Barr virus-related post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantation.

Michael Uhlin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.